These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6756531)

  • 1. Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity.
    Charney DS; Heninger GR; Sternberg DE; Landis H
    Br J Psychiatry; 1982 Oct; 141():377-86. PubMed ID: 6756531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of anxiety on total plasma MHPG in depressed patients.
    Karege F; Bovier P; Hilleret H; Gaillard JM
    J Affect Disord; 1993 Jul; 28(3):211-7. PubMed ID: 8408983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action.
    Charney DS; Price LH; Heninger GR
    Arch Gen Psychiatry; 1986 Dec; 43(12):1155-61. PubMed ID: 3022664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
    Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review.
    Yoshimura R; Nakamura J; Shinkai K; Ueda N
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):611-6. PubMed ID: 15276685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic-induced mania and MHPG excretion.
    Zis AP; Cowdry RW; Wehr TA; Muscettola G; Goodwin FK
    Psychiatry Res; 1979 Jul; 1(1):93-9. PubMed ID: 298343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
    McDougle CJ; Black JE; Malison RT; Zimmermann RC; Kosten TR; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Sep; 51(9):713-9. PubMed ID: 8080348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomania and mania after withdrawal of tricyclic antidepressants.
    Mirin SM; Schatzberg AF; Creasey DE
    Am J Psychiatry; 1981 Jan; 138(1):87-9. PubMed ID: 7446789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies on norepinephrine metabolism: how to interpret the numbers.
    Linnoila M; Guthrie S; Lane EA; Karoum F; Rudorfer M; Potter WZ
    Psychiatry Res; 1986 Mar; 17(3):229-39. PubMed ID: 2939486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients.
    Azorin JM; Karege F; Valli M; Pringuey D; Joanny P; Tissot R
    Neuropsychobiology; 1988; 20(2):67-73. PubMed ID: 3075724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
    Crawley JN; Laverty R; Roth RH
    Eur J Pharmacol; 1979 Aug; 57(2-3):247-50. PubMed ID: 573692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mianserin on alpha-2 adrenergic receptor function in depressed patients.
    Charney DS; Heninger GR; Sternberg DE
    Br J Psychiatry; 1984 Apr; 144():407-16. PubMed ID: 6326924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G; Wetzel H; Schlösser R; Benkert O
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do low levels of MHPG in depressive spectrum patients normalize after successful treatment?
    Garvey MJ; Tuason VB
    Neuropsychobiology; 1996; 34(4):188-91. PubMed ID: 9121619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
    Golden RN; Markey SP; Risby ED; Rudorfer MV; Cowdry RW; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):150-4. PubMed ID: 3122700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic output and clinical response in depressed women during amitriptyline therapy.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Pharmacopsychiatry; 1989 Jul; 22(4):144-51. PubMed ID: 2762377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.